There hasn't been a peep out of Oxford Nanopore Technologies since the company announced in February that its DNA strand sequencing nanopore method is working and that it is developing it commercially. "When will nanopores actually hit the market?" asks Keith Robison at his Omics! Omics! blog.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.